1. Home
  2. SCLX vs DFLI Comparison

SCLX vs DFLI Comparison

Compare SCLX & DFLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scilex Holding Company

SCLX

Scilex Holding Company

HOLD

Current Price

$6.57

Market Cap

52.9M

Sector

Health Care

ML Signal

HOLD

Logo Dragonfly Energy Holdings Corp. (NV)

DFLI

Dragonfly Energy Holdings Corp. (NV)

HOLD

Current Price

$1.77

Market Cap

49.0M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCLX
DFLI
Founded
2011
2020
Country
United States
United States
Employees
30
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Electronic Components
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
52.9M
49.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SCLX
DFLI
Price
$6.57
$1.77
Analyst Decision
Hold
Strong Buy
Analyst Count
1
1
Target Price
N/A
$3.25
AVG Volume (30 Days)
30.1K
424.3K
Earning Date
05-13-2026
03-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$749.70
$51.17
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.18
$0.15
52 Week High
$34.27
$5.15

Technical Indicators

Market Signals
Indicator
SCLX
DFLI
Relative Strength Index (RSI) 30.61 31.33
Support Level $4.56 $0.25
Resistance Level $7.50 $2.74
Average True Range (ATR) 0.64 0.24
MACD -0.13 -0.06
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
SCLX
DFLI

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

About DFLI Dragonfly Energy Holdings Corp. (NV)

Dragonfly Energy Holdings Corp is a manufacturer of non-toxic deep cycle lithium-ion batteries that are designed to displace lead acid batteries in a number of different storage applications and end markets including RV, marine vessel, and solar and off-grid industries, with disruptive solid-state cell technology currently under development. The company's deep cycle lithium iron phosphate ("LFP") batteries provide numerous advantages compared to incumbent products, such as lead-acid batteries. LFP batteries are non-toxic and environmentally friendly, do not rely on scarce or controversial metals, and are a cost-effective storage solution.

Share on Social Networks: